🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to investigate safety and tolerabili...
Status
Completed
Location
The Medicines Evaluation Unit
Start Date
2017-05-18
Trial ID
NCT03135899
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
Multicenter, double-blind, randomized, placebo-controlled phase I/II study ...
Status
Recruiting
Location
Clinica Universidad de Navarra
Start Date
2020-03-11
Trial ID
NCT04163562
This is a First in Human (FIH), double-blinded, parallel-group, randomised,...
Status
Completed
Location
CTC Clinical Trial Consultants AB
Start Date
2019-07-03
Trial ID
NCT04036227
This study evaluates and compares the effects of two different kinesio tapi...
Status
Completed
Location
Zeynep Kamil Women's and Children's Disease Training and Research Hospital
Start Date
2020-01-27
Trial ID
NCT04139603
Treatments Being Tested
Study to investigate the safety profile of AZD4721 after single doses at di...
Status
Completed
Location
Research Site
Start Date
2013-07
Trial ID
NCT01889160
Treatments Being Tested
This is a Phase I Randomised Single-blind Placebo-controlled Study to Asses...
Status
Completed
Location
Research Site
Start Date
2023-05-02
Trial ID
NCT05848440
Part A: The primary objective is to evaluate the safety and tolerability of...
Status
Completed
Location
Biokinetic Europ Ltd
Start Date
2015-05
Trial ID
NCT02459262
Treatments Being Tested
The study is a single centre, phase I, double-blind, randomized, placebo-co...
Status
Completed
Location
Kazakh National Medical University
Start Date
2016-05
Trial ID
NCT03028116
Treatments Being Tested
This is a Phase 1, two-part, randomized, double blind, placebo controlled, ...
Status
Completed
Location
Scientia Clinical Research Ltd
Start Date
2022-06-07
Trial ID
NCT05364840